Daniela Rodarte

This study identifies miR-501-3p and miR-502-3p as potential biomarkers for Alzheimer's disease by showing their upregulation in AD-related samples.

This study examines how miR-502-3p affects GABA A subunits, synaptic proteins, mitochondrial morphology, and gene expression in hippocampal neurons.

The paper identifies miRNA expression changes and distribution in soma and synapses of the substantia nigra in Parkinson's disease and controls.

This study investigates the in vivo effects of miR-502-3p overexpression and suppression on synaptic activity, mitochondrial morphology, and dendritic spine density in mice.

The paper identifies synapse-centered molecular targets in Alzheimer's disease through integrated multi-omics analysis of synaptosomes from postmortem brain samples.